Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

When hearing about new uses of AI, I think some people imagine the innovation is just asking ChatGPT a question. If that was truly happening, that should inspire a lot ...

Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.

Discover why Cartesian Therapeutics, Inc. earns a Buy rating with strong CAR-T pipeline progress and market growth in ...

Last week, Canada officially lost its measles elimination status, which it held for nearly 30 years — a shameful consequence of falling childhood vaccination rates.

The study was published in Nature Biotechnology last month and marks a shift in scientists’ understanding of how to ...

After getting vaccinated against COVID, Kirsch became convinced that the shot was unsafe and began campaigning against it. He ...

The fate of CureVac hangs in the balance as shareholders approach a pivotal deadline that will determine whether the Tübingen-based biotech firm maintains it ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...